These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20199123)

  • 1. Targeted therapies in cancer.
    Ciavarella S; Milano A; Dammacco F; Silvestris F
    BioDrugs; 2010 Apr; 24(2):77-88. PubMed ID: 20199123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.
    Hojjat-Farsangi M
    J Drug Target; 2016; 24(3):192-211. PubMed ID: 26211367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in the study of targeted drug delivery systems for cancer stem cells].
    Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
    Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for targeted therapy of bladder cancer.
    Agarwal PK; Black PC; McConkey DJ; Dinney CP
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):435-48. PubMed ID: 17874971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms.
    Kanwar JR; Samarasinghe RM; Kamalapuram SK; Kanwar RK
    Mini Rev Med Chem; 2017; 17(18):1688-1695. PubMed ID: 26891936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Therapeutics, Molecular Targets, Pharmacology and Clinical Applications--First International Conference 19-21 February 2004, Florence, Italy.
    Roberts J
    IDrugs; 2004 Apr; 7(4):301-5. PubMed ID: 15057630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of targeted therapies in oncology.
    Kalyn R
    J Oncol Pharm Pract; 2007 Dec; 13(4):199-205. PubMed ID: 18045779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase inhibitors to treat liver cancer.
    Huynh H
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):13-26. PubMed ID: 20128706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues.
    Christoffersen T; Guren TK; Spindler KL; Dahl O; Lønning PE; Gjertsen BT
    Eur J Pharmacol; 2009 Dec; 625(1-3):6-22. PubMed ID: 19836383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cancer therapeutics.
    Hait WN; Hambley TW
    Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New phosphatidylinositol 3-kinase inhibitors for cancer.
    Bowles DW; Jimeno A
    Expert Opin Investig Drugs; 2011 Apr; 20(4):507-18. PubMed ID: 21395485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile of new anticancer drugs.
    Mansi L; Thiery-Vuillemin A; Nguyen T; Bazan F; Calcagno F; Rocquain J; Demarchi M; Villanueva C; Maurina T; Pivot X
    Expert Opin Drug Saf; 2010 Mar; 9(2):301-17. PubMed ID: 20175699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells: the development of new cancer therapeutics.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.